A Dual Targeting Magnetic Nanoparticle for Human Cancer Detection

Abstract Malignant tumors are a major threat to human life and high lymphatic vessel density is often associated with metastatic tumors. With the discovery of molecules targeted at the lymphatic system such as lymphatic vessel endothelial hyaluronan receptor 1 (LYVE-1) and Podoplanin, many studies h...

Full description

Bibliographic Details
Main Authors: Siwen Wu, Xiyu Liu, Jian He, Huiling Wang, Yiqun Luo, Wenlin Gong, Yanmei Li, Yong Huang, Liping Zhong, Yongxiang Zhao
Format: Article
Language:English
Published: SpringerOpen 2019-07-01
Series:Nanoscale Research Letters
Subjects:
Online Access:http://link.springer.com/article/10.1186/s11671-019-3049-0
id doaj-9a47c1fd1e8944db8c46d66daf2a9c60
record_format Article
spelling doaj-9a47c1fd1e8944db8c46d66daf2a9c602020-11-25T03:36:42ZengSpringerOpenNanoscale Research Letters1931-75731556-276X2019-07-0114111110.1186/s11671-019-3049-0A Dual Targeting Magnetic Nanoparticle for Human Cancer DetectionSiwen Wu0Xiyu Liu1Jian He2Huiling Wang3Yiqun Luo4Wenlin Gong5Yanmei Li6Yong Huang7Liping Zhong8Yongxiang Zhao9National Center for International Research of Bio-targeting Theranostics, Guangxi Key Laboratory of Bio-targeting Theranostics, Collaborative InnovationCenter for Targeting Tumor Diagnosis and Therapy, Guangxi Medical UniversityNational Center for International Research of Bio-targeting Theranostics, Guangxi Key Laboratory of Bio-targeting Theranostics, Collaborative InnovationCenter for Targeting Tumor Diagnosis and Therapy, Guangxi Medical UniversityNational Center for International Research of Bio-targeting Theranostics, Guangxi Key Laboratory of Bio-targeting Theranostics, Collaborative InnovationCenter for Targeting Tumor Diagnosis and Therapy, Guangxi Medical UniversityNational Center for International Research of Bio-targeting Theranostics, Guangxi Key Laboratory of Bio-targeting Theranostics, Collaborative InnovationCenter for Targeting Tumor Diagnosis and Therapy, Guangxi Medical UniversityNational Center for International Research of Bio-targeting Theranostics, Guangxi Key Laboratory of Bio-targeting Theranostics, Collaborative InnovationCenter for Targeting Tumor Diagnosis and Therapy, Guangxi Medical UniversityNational Center for International Research of Bio-targeting Theranostics, Guangxi Key Laboratory of Bio-targeting Theranostics, Collaborative InnovationCenter for Targeting Tumor Diagnosis and Therapy, Guangxi Medical UniversityNational Center for International Research of Bio-targeting Theranostics, Guangxi Key Laboratory of Bio-targeting Theranostics, Collaborative InnovationCenter for Targeting Tumor Diagnosis and Therapy, Guangxi Medical UniversityNational Center for International Research of Bio-targeting Theranostics, Guangxi Key Laboratory of Bio-targeting Theranostics, Collaborative InnovationCenter for Targeting Tumor Diagnosis and Therapy, Guangxi Medical UniversityNational Center for International Research of Bio-targeting Theranostics, Guangxi Key Laboratory of Bio-targeting Theranostics, Collaborative InnovationCenter for Targeting Tumor Diagnosis and Therapy, Guangxi Medical UniversityNational Center for International Research of Bio-targeting Theranostics, Guangxi Key Laboratory of Bio-targeting Theranostics, Collaborative InnovationCenter for Targeting Tumor Diagnosis and Therapy, Guangxi Medical UniversityAbstract Malignant tumors are a major threat to human life and high lymphatic vessel density is often associated with metastatic tumors. With the discovery of molecules targeted at the lymphatic system such as lymphatic vessel endothelial hyaluronan receptor 1 (LYVE-1) and Podoplanin, many studies have been performed to determine the role of lymphatic endothelial cells (LECs) in tumor metastasis. However, disadvantages such as non-specificity and high cost limit their research and diagnostic applications. In this study, Fe3O4@KCTS, a core-shell type of magnetic nanoparticles, was prepared by activating Fe3O4 with carbodiimide and cross-linking it with α-ketoglutarate chitosan (KCTS). The LYVE-1 and Podoplanin antibodies were then incorporated onto the surface of these magnetic nanoparticles and as a result, dual-targeting magnetic nanoprobes were developed. The experimental tests of this study demonstrated that a dual-targeting magnetic nanoprobe with high-purity LECs from tumor tissues was successfully developed, providing a basis for clinical application of LECs in colorectal cancer treatment as well as in early clinical diagnosis using bimodal imaging.http://link.springer.com/article/10.1186/s11671-019-3049-0Lymphatic endothelial cellsPodoplaninLYVE-1Magnetic nanoparticles
collection DOAJ
language English
format Article
sources DOAJ
author Siwen Wu
Xiyu Liu
Jian He
Huiling Wang
Yiqun Luo
Wenlin Gong
Yanmei Li
Yong Huang
Liping Zhong
Yongxiang Zhao
spellingShingle Siwen Wu
Xiyu Liu
Jian He
Huiling Wang
Yiqun Luo
Wenlin Gong
Yanmei Li
Yong Huang
Liping Zhong
Yongxiang Zhao
A Dual Targeting Magnetic Nanoparticle for Human Cancer Detection
Nanoscale Research Letters
Lymphatic endothelial cells
Podoplanin
LYVE-1
Magnetic nanoparticles
author_facet Siwen Wu
Xiyu Liu
Jian He
Huiling Wang
Yiqun Luo
Wenlin Gong
Yanmei Li
Yong Huang
Liping Zhong
Yongxiang Zhao
author_sort Siwen Wu
title A Dual Targeting Magnetic Nanoparticle for Human Cancer Detection
title_short A Dual Targeting Magnetic Nanoparticle for Human Cancer Detection
title_full A Dual Targeting Magnetic Nanoparticle for Human Cancer Detection
title_fullStr A Dual Targeting Magnetic Nanoparticle for Human Cancer Detection
title_full_unstemmed A Dual Targeting Magnetic Nanoparticle for Human Cancer Detection
title_sort dual targeting magnetic nanoparticle for human cancer detection
publisher SpringerOpen
series Nanoscale Research Letters
issn 1931-7573
1556-276X
publishDate 2019-07-01
description Abstract Malignant tumors are a major threat to human life and high lymphatic vessel density is often associated with metastatic tumors. With the discovery of molecules targeted at the lymphatic system such as lymphatic vessel endothelial hyaluronan receptor 1 (LYVE-1) and Podoplanin, many studies have been performed to determine the role of lymphatic endothelial cells (LECs) in tumor metastasis. However, disadvantages such as non-specificity and high cost limit their research and diagnostic applications. In this study, Fe3O4@KCTS, a core-shell type of magnetic nanoparticles, was prepared by activating Fe3O4 with carbodiimide and cross-linking it with α-ketoglutarate chitosan (KCTS). The LYVE-1 and Podoplanin antibodies were then incorporated onto the surface of these magnetic nanoparticles and as a result, dual-targeting magnetic nanoprobes were developed. The experimental tests of this study demonstrated that a dual-targeting magnetic nanoprobe with high-purity LECs from tumor tissues was successfully developed, providing a basis for clinical application of LECs in colorectal cancer treatment as well as in early clinical diagnosis using bimodal imaging.
topic Lymphatic endothelial cells
Podoplanin
LYVE-1
Magnetic nanoparticles
url http://link.springer.com/article/10.1186/s11671-019-3049-0
work_keys_str_mv AT siwenwu adualtargetingmagneticnanoparticleforhumancancerdetection
AT xiyuliu adualtargetingmagneticnanoparticleforhumancancerdetection
AT jianhe adualtargetingmagneticnanoparticleforhumancancerdetection
AT huilingwang adualtargetingmagneticnanoparticleforhumancancerdetection
AT yiqunluo adualtargetingmagneticnanoparticleforhumancancerdetection
AT wenlingong adualtargetingmagneticnanoparticleforhumancancerdetection
AT yanmeili adualtargetingmagneticnanoparticleforhumancancerdetection
AT yonghuang adualtargetingmagneticnanoparticleforhumancancerdetection
AT lipingzhong adualtargetingmagneticnanoparticleforhumancancerdetection
AT yongxiangzhao adualtargetingmagneticnanoparticleforhumancancerdetection
AT siwenwu dualtargetingmagneticnanoparticleforhumancancerdetection
AT xiyuliu dualtargetingmagneticnanoparticleforhumancancerdetection
AT jianhe dualtargetingmagneticnanoparticleforhumancancerdetection
AT huilingwang dualtargetingmagneticnanoparticleforhumancancerdetection
AT yiqunluo dualtargetingmagneticnanoparticleforhumancancerdetection
AT wenlingong dualtargetingmagneticnanoparticleforhumancancerdetection
AT yanmeili dualtargetingmagneticnanoparticleforhumancancerdetection
AT yonghuang dualtargetingmagneticnanoparticleforhumancancerdetection
AT lipingzhong dualtargetingmagneticnanoparticleforhumancancerdetection
AT yongxiangzhao dualtargetingmagneticnanoparticleforhumancancerdetection
_version_ 1724548644403675136